Sex Tape May Have Triggered China's Major Crackdown On Drug Makers
This article was originally published in PharmAsia News
China's major crackdown on drug companies suspected of paying bribes may have been triggered by a sex involving GlaxoSmithKline's U.K.-born chief executive in China that was sent to senior executives, including CEO Andrew Witty.
You may also be interested in...
Amgen’s management took a deep dive into biosimilar market dynamics during the company’s third-quarter earnings call, as the California-based biotech continued to enjoy success for biosimilars in the US and Europe.
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
Russia seeks WHO endorsement of its Sputnik V vaccine, a UK BioIndustry Association task force identifies potential new antibody cocktails, and the European Centre for Disease Prevention and Control considers the best strategies for targeted vaccination programs.